Concerns Arise Over Gene Therapy Viruses and Tumor Link in Young Patient
Recent findings suggest a potential connection between gene therapy viruses and a tumor in a young boy, raising important questions about the safety of such treatments.
Safety-Enhancing Drug for Gene Therapy Raises Effectiveness Concerns
Encoded Therapeutics has alerted gene therapy firms about potential trade-offs associated with a drug designed to enhance safety, which may inadvertently reduce effectiveness.
Gene Therapy Risks Highlighted by Rare Tumor Case in Boy
A boy's tumor has been linked to gene therapy viruses, prompting doctors to emphasize the need for careful consideration of the rare risks versus the significant benefits of such treatments.
FDA Faces Leadership Challenges Amid Hantavirus Concerns
The recent resignation of the FDA head has raised alarms about the agency's stability, with Kyle Diamantas stepping in as acting leader during a critical time.
Marty Makary Resigns as FDA Commissioner Amid Ongoing Challenges
In a significant shift at the Food and Drug Administration, Commissioner Marty Makary is stepping down following a challenging period in leadership, with Diamantas taking over.
Hims Faces Sales Challenges Amid Rising Telehealth Competition
As competition in the telehealth sector intensifies, Hims has reported a decline in sales. The company is navigating a challenging landscape, with significant developments in the biotech field.
A Closer Look at America's Struggle with Alcohol Abuse
STAT highlights the ongoing challenges America faces in tackling excessive alcohol consumption, revealing a historical pattern of neglect.
Pharmaceutical Lobbying Sees Significant Increase; Bristol-Myers Forms New Partnership in China
Pharmaceutical companies have ramped up their lobbying efforts, spending over $130 million in 2025, while Bristol-Myers Squibb has announced a new partnership with a Chinese firm.
Capsida Remains Unclear on Cause of Gene Therapy-Related Death
The gene therapy community expresses concern over the lack of information from Capsida regarding the brain receptor involved in a recent fatal incident.
The Promise of Generative AI in Reducing Animal Testing
Researchers are investigating how generative AI could potentially decrease the reliance on animal experiments in drug development, addressing ethical concerns.
Understanding the Grief of Pets After Losing a Companion
The emotional toll of losing a pet extends beyond humans, affecting surviving animals as well. This piece reflects on the grief experienced by both parties.
Unexpected Decline in Alzheimer’s Drug Usage Among Seniors
Recent reports indicate that significantly fewer seniors are utilizing expensive Alzheimer's medications than initially anticipated by Medicare.
Astellas' New Treatment Brings Hope to Rare Disease Patients
Recent developments in biotech include Astellas' promising treatment for rare diseases, amid challenges in Alzheimer's drug rollout and insights from a China-based heart drug startup.
A New Hope for XLMTM Treatment Five Years After Tragedy
Following a challenging period marked by both remarkable recoveries and tragic losses, Astellas is revisiting its gene therapy approach for XLMTM, offering renewed hope to affected families.
Dr. Glaucomflecken Advocates for Local Medicine Amid Corporatization Concerns
In a recent discussion, Dr. Glaucomflecken highlights the necessity of maintaining local medical practices to better serve patients and communities, urging for national attention on the issue.
Innovative Grain-of-Rice Sensor Enhances Robotic and Medical Capabilities
A new sensor, comparable in size to a grain of rice, promises to significantly improve the functionality of robots and medical devices by measuring forces and twisting motions using light.
Capricor Therapeutics Claims Nippon Shinyaku Delays Duchenne Drug Rollout
Capricor Therapeutics has raised concerns about Nippon Shinyaku and its U.S. branch regarding the implementation of a treatment for Duchenne muscular dystrophy.
Innovative Nanoparticles Tackle Drug-Resistant Cancer Challenges
Recent findings highlight the potential of nanoparticles in fighting drug-resistant cancer, offering new hope for improving chemotherapy outcomes through advanced treatment methods.
Key Biotech Updates: Lawsuits and Regulatory Challenges
Today's biotech news highlights a lawsuit concerning Duchenne therapy and challenges faced by FDA Commissioner Marty Makary in relation to the White House.
Understanding the GENEROUS Model and Its Potential Effects on Medicaid Drug Pricing
This brief outlines the GENEROUS model and explores various elements that may influence Medicaid drug costs, emphasizing the importance of confidentiality regarding certain model details.